CBX4 and hepatocellular carcinoma: Contrary to what was seen in Cbx4-overexpressed HCC cells, Cbx4 silencing remarkably increased IC50 of doxorubicin in SMMC-7721 cells (Figure 5c), and especially in MHCC97L cells (Figure 5d).